<p>Top: CHI3L1 protein concentrations in human serum. Bottom: ROC (Receiver Operating Characteristic) curve analysis to determine the area under the curve (AUC). Mean ± SD in control (n>30): 17.3±7.8. Mean ± SD in adenocarcinoma (n>30): 66.9±64.8. Mean ± SD in squamous carcinoma (n>30): 69.3±69.0. Mean ± SD in small cell cancer (n>30): 56.3±58.8. The gray lines represent the mean values. Control: Normal human without cancer.</p
<p>Single proteins (A) and multi-marker models (B) were used for the classification analyses. For mu...
<p>Chi<sup>2</sup>: Chi-square test; PD-L1: programmed death-ligand-1; NSCLC: non-small cell lung ca...
The detection of serum biomarkers can aid in the diagnosis of lung cancer. In recent years, an incre...
<p>Left: CHI3L1 protein concentrations in BALF and serum of doxycycline-treated and untreated bitran...
<p>Left: CHI3L1 protein concentrations in BALF and serum of doxycycline-treated and untreated bitran...
<p>Scatter plot demonstrating a highly significant elevation of (<b>A</b>) AGR3 and (<b>C</b>) AGR2 ...
<p>Serum levels of <b>(A)</b> BCHE and <b>(B)</b> GPx3 in the control and NSCLC groups. <b>(C)</b> R...
<p>(A). Distribution of the serum OD value in cholangiocarcinoma (CC) patients, patients with benign...
<p>A: DCLK1 protein levels in the serum samples were determined by ELISA. DCLK1 levels were grouped ...
ROC curve analysis of TK 210 ELISA and TK1 activity assay for different malignancies at a specificit...
Background/Aims: The chitinase 3-like 1 (CHI3L1) has an important role in cancer progression, and hi...
<p>(A,B) ROC analysis of lung cancer patients and healthy controls, and healthy controls as a negati...
<p>The dot plot (upper left) of the relative abundance, ROC curve (upper right) and the diagnostic p...
<p>Serum CAXII levels in patients with lung cancer and healthy controls. (A) The median CAXII level ...
Aims-To compare the two breast tumour markers, CA15-3 and mucinous-like carcinoma associated antigen...
<p>Single proteins (A) and multi-marker models (B) were used for the classification analyses. For mu...
<p>Chi<sup>2</sup>: Chi-square test; PD-L1: programmed death-ligand-1; NSCLC: non-small cell lung ca...
The detection of serum biomarkers can aid in the diagnosis of lung cancer. In recent years, an incre...
<p>Left: CHI3L1 protein concentrations in BALF and serum of doxycycline-treated and untreated bitran...
<p>Left: CHI3L1 protein concentrations in BALF and serum of doxycycline-treated and untreated bitran...
<p>Scatter plot demonstrating a highly significant elevation of (<b>A</b>) AGR3 and (<b>C</b>) AGR2 ...
<p>Serum levels of <b>(A)</b> BCHE and <b>(B)</b> GPx3 in the control and NSCLC groups. <b>(C)</b> R...
<p>(A). Distribution of the serum OD value in cholangiocarcinoma (CC) patients, patients with benign...
<p>A: DCLK1 protein levels in the serum samples were determined by ELISA. DCLK1 levels were grouped ...
ROC curve analysis of TK 210 ELISA and TK1 activity assay for different malignancies at a specificit...
Background/Aims: The chitinase 3-like 1 (CHI3L1) has an important role in cancer progression, and hi...
<p>(A,B) ROC analysis of lung cancer patients and healthy controls, and healthy controls as a negati...
<p>The dot plot (upper left) of the relative abundance, ROC curve (upper right) and the diagnostic p...
<p>Serum CAXII levels in patients with lung cancer and healthy controls. (A) The median CAXII level ...
Aims-To compare the two breast tumour markers, CA15-3 and mucinous-like carcinoma associated antigen...
<p>Single proteins (A) and multi-marker models (B) were used for the classification analyses. For mu...
<p>Chi<sup>2</sup>: Chi-square test; PD-L1: programmed death-ligand-1; NSCLC: non-small cell lung ca...
The detection of serum biomarkers can aid in the diagnosis of lung cancer. In recent years, an incre...